LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-29
Latest data update time: Updated on 2026-03-29
5.70 / 10Overall Score
NeturalInvestment Rating
5.70 / 10Overall Score
NeturalInvestment Rating
Should I Buy LIMN Now?
- Based on a composite score of 5.70/10, we rate LIMN as a Netural. Our analysis breaks down into 9.00/10 for Fundamentals, 1.00/10 for Technicals, and 7.10/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for LIMN?
Is LIMN fundamentally strong?
What is the market sentiment for LIMN?
Should I Buy LIMN Now?
- Based on a composite score of 5.70/10, we rate LIMN as a Netural. Our analysis breaks down into 9.00/10 for Fundamentals, 1.00/10 for Technicals, and 7.10/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is LIMN fundamentally strong?
What is the current technical signals for LIMN?
What is the market sentiment for LIMN?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
